A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis
- 31 July 2002
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (10) , 1358-1363
- https://doi.org/10.1016/s0959-8049(02)00102-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Analgesic Effects of Nonsteroidal Anti-inflammatory Drugs in Cancer Pain Due to Somatic or Visceral MechanismsJournal of Pain and Symptom Management, 1999
- The Opioid-Sparing Effects of Intravenous Ketorolac as an Adjuvant Analgesic in Cancer PainJournal of Pain and Symptom Management, 1998
- Similar pain in different countriesJournal of Pain and Symptom Management, 1996
- Ketorolac continuous infusion: A case report and review of the literatureJournal of Pain and Symptom Management, 1996
- Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective studyPain, 1995
- Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphineEuropean Journal Of Cancer, 1994
- Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related painPublished by Oxford University Press (OUP) ,1994
- Subcutaneous ketorolac- a new development in pain controlPalliative Medicine, 1993
- Predictive factors in advanced cancer pain treated only by analgesicsPain, 1992
- A Double‐Blind Study with Placebo Control of Intramuscular Ketorolac Tromethamine in the Treatment of Cancer PainThe Journal of Clinical Pharmacology, 1989